Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BISOPROLOL Cause Intentional product use issue? 384 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 384 reports of Intentional product use issue have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 1.4% of all adverse event reports for BISOPROLOL.

384
Reports of Intentional product use issue with BISOPROLOL
1.4%
of all BISOPROLOL reports
3
Deaths
152
Hospitalizations

How Dangerous Is Intentional product use issue From BISOPROLOL?

Of the 384 reports, 3 (0.8%) resulted in death, 152 (39.6%) required hospitalization, and 77 (20.1%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 384 reports have been filed with the FAERS database.

What Other Side Effects Does BISOPROLOL Cause?

Dyspnoea (2,940) Bradycardia (2,535) Hypotension (2,504) Dizziness (2,153) Fall (2,011) Fatigue (1,983) Acute kidney injury (1,894) Malaise (1,602) Drug ineffective (1,486) Nausea (1,460)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which BISOPROLOL Alternatives Have Lower Intentional product use issue Risk?

BISOPROLOL vs BISOPROLOL\BISOPROLOL BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE BISOPROLOL vs BIVALIRUDIN BISOPROLOL vs BLEOMYCIN BISOPROLOL vs BLINATUMOMAB

Related Pages

BISOPROLOL Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue BISOPROLOL Demographics